# Eli Lilly and Company (LLY) — Q2-2011 Earnings Results

**Report date:** 2011-07-21 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q2-2011

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS, Stock Up 3.01%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.18 | N/A | -0.59% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook despite the slight EPS miss. They emphasized their commitment to innovation and market expansion.

**Key quotes:**

> Management expressed confidence in the long-term growth strategy.

> They highlighted ongoing investments in research and development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report showed a slight miss on EPS, which typically raises concerns among investors. However, the stock rose by 3.01%, indicating that investors are optimistic about the company's long-term strategy and growth potential. Management's focus on research and development may have reassured investors despite the EPS miss.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q2-2011_